telmisartan has been researched along with Kidney Failure, Chronic in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 12 (63.16) | 29.6817 |
| 2010's | 6 (31.58) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abebe, KZ; Braun, WE; Brosnahan, G; Chapman, AB; Czarnecki, PG; Flessner, MF; Grantham, JJ; Harris, PC; Hogan, MC; Miskulin, DC; Moore, CG; Perrone, RD; Rahbari-Oskoui, FF; Schrier, RW; Steinman, TI; Torres, VE; Winklhofer, FT | 1 |
| Galle, J | 1 |
| Bakris, GL; Sarafidis, PA | 1 |
| Inoue, T; Kawagoe, Y; Nakamura, T; Node, K; Sugaya, T; Suzuki, T; Ueda, Y | 1 |
| Abe, H; Fujimoto, Y; Furuno, Y; Kabashima, N; Matsumoto, M; Miyamoto, T; Miyazaki, M; Nakamata, J; Okazaki, M; Otsuji, Y; Serino, R; Shibata, T; Takeuchi, M; Tamura, M; Tokunaga, M | 1 |
| Fujiwara, N; Kawagoe, Y; Koide, H; Nakamura, T; Sugaya, T; Ueda, Y | 1 |
| Clase, CM; Gao, P; Grosshennig, A; Mann, JF; McQueen, M; Teo, KK; Tobe, SW; Wang, X; Yusuf, S | 1 |
| Akizawa, T; Aoshima, Y; Hirai, Y; Honda, H; Hosaka, N; Michihata, T | 1 |
| Kobara, M; Nakata, T; Noda, K; Toba, H; Tojo, C; Wang, J | 1 |
| Konecný, K; Kosatíková, Z; Metelka, R; Vymetal, J; Weinbergová, O | 1 |
| Zidek, W | 1 |
| Hollander, A; Köster, J; Sharma, AM | 1 |
| Merta, M; Rysavá, R; Tesar, V | 1 |
| Aranda, FJ; Aranda, P; Frutos, MA; López de Novales, E; López, V; Ruilope, LM; Segura, J | 1 |
| Barnett, A | 2 |
| Cibulskyte, D; Frøkiaer, J; Hansen, HE; Hørlyck, A; Madsen, M; Marcussen, N; Mortensen, J; Pedersen, M | 1 |
| Koide, H; Nakamura, T; Sugaya, T | 1 |
| Zanchetti, A | 1 |
3 review(s) available for telmisartan and Kidney Failure, Chronic
| Article | Year |
|---|---|
Reduction of proteinuria with angiotensin receptor blockers.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Biomarkers; Cardiovascular Diseases; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2008 |
Prevention of loss of renal function over time in patients with diabetic nephropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Agents; Diabetic Nephropathies; Enalapril; Glomerular Filtration Rate; Humans; Kidney; Kidney Failure, Chronic; Proteinuria; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan; Time Factors; Treatment Outcome | 2006 |
Impact of hypertension and antihypertensive treatment on organ damage.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Carotid Stenosis; Cause of Death; Clinical Trials as Topic; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Survival Rate; Telmisartan; Treatment Outcome | 1999 |
10 trial(s) available for telmisartan and Kidney Failure, Chronic
| Article | Year |
|---|---|
Angiotensin blockade in late autosomal dominant polycystic kidney disease.
Topics: Adolescent; Adult; Albuminuria; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Renal Insufficiency, Chronic; Telmisartan; Young Adult | 2014 |
Renoprotective effect of telmisartan in patients with chronic kidney disease.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Collagen Type IV; Creatinine; Fatty Acid-Binding Proteins; Female; Glomerular Filtration Rate; Heart Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Proteinuria; Telmisartan; Time Factors | 2008 |
Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Enalapril; Endothelin-1; Fatty Acid-Binding Proteins; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Proteinuria; Telmisartan | 2010 |
Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies.
Topics: Aged; Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Creatinine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Heart Failure; Heart Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Ramipril; Stroke; Telmisartan; Treatment Outcome | 2011 |
Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Pressure; Female; Glycation End Products, Advanced; Humans; Hypertension, Renal; Imidazoles; Inflammation; Kidney Failure, Chronic; Lysine; Male; Olmesartan Medoxomil; Oxidative Stress; Pilot Projects; Prospective Studies; Renal Dialysis; Telmisartan; Tetrazoles; Treatment Outcome | 2012 |
Telmisartan in the treatment of hypertension in patients with chronic renal insufficiency.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Diabetic Nephropathies; Female; Heart Rate; Humans; Hypertension, Renal; Kidney Failure, Chronic; Male; Telmisartan | 2004 |
Telmisartan in patients with mild/moderate hypertension and chronic kidney disease.
Topics: Administration, Oral; Adult; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Single-Blind Method; Telmisartan; Treatment Outcome | 2005 |
Effect of telmisartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease.
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Proteinuria; Severity of Illness Index; Telmisartan | 2005 |
Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Creatinine; Dose-Response Relationship, Drug; Dyslipidemias; Female; Follow-Up Studies; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Proteinuria; Renin-Angiotensin System; Telmisartan; Treatment Outcome | 2005 |
Preventing renal complications in type 2 diabetes: results of the diabetics exposed to telmisartan and enalapril trial.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Creatinine; Diabetes Complications; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Enalapril; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney Failure, Chronic; Receptors, Angiotensin; Renin-Angiotensin System; Telmisartan | 2006 |
6 other study(ies) available for telmisartan and Kidney Failure, Chronic
| Article | Year |
|---|---|
Renin-angiotensin blockade and kidney disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Ramipril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan | 2008 |
Renoprotective effects of telmisartan in patients with advanced chronic kidney disease.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Retrospective Studies; Telmisartan; Treatment Outcome | 2010 |
Telmisartan inhibits vascular dysfunction and inflammation via activation of peroxisome proliferator-activated receptor-γ in subtotal nephrectomized rat.
Topics: Acetylcholine; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Aorta; Benzimidazoles; Benzoates; Blood Urea Nitrogen; Disease Models, Animal; Inflammation; Kidney Failure, Chronic; Losartan; Male; Malondialdehyde; Nephrectomy; PPAR gamma; Rats; Rats, Wistar; Telmisartan; Vasodilation | 2012 |
[Diabetes and Nephropathy: ACE inhibitor for type 1, AT1 blocker for type 2].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Long-Term Care; Renal Dialysis; Telmisartan; Treatment Outcome | 2004 |
Telmisartan attenuates chronic ciclosporin A nephrotoxicity in a pig model.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Biopsy; Blood Flow Velocity; Blood Pressure; Cyclosporine; Disease Models, Animal; Female; Follow-Up Studies; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Magnetic Resonance Imaging; Renal Circulation; Swine; Telmisartan; Treatment Outcome | 2007 |
Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Creatinine; Diabetic Nephropathies; Fatty Acid-Binding Proteins; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Telmisartan | 2007 |